Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Sino Biopharmaceutical (SBMFF) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$3.43B |
|
$401.53M |
|
$750.92M |
|
$2.68B |
|
$2.65B |
|
$773.71M |
|
$-47.32M |
|
$726.39M |
|
$726.86M |
|
$628.96M |
|
$628.96M |
|
$628.96M |
|
$629.49M |
|
$773.71M |
|
$1.00B |
|
18.80B |
|
18.80B |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$3.30B |
|
$995.50M |
|
$3.54B |
|
$6.84B |
|
$1.59B |
|
$1.86B |
|
$2.01B |
|
$3.59B |
|
$3.25B |
|
$3.10B |
|
$3.25B |
|
18.86B |
|
| Cash Flow Statement Financials | |
$771.64M |
|
$-1.14B |
|
$323.59M |
|
$1.54B |
|
$1.54B |
|
$-1.02M |
|
-- |
|
$-393.34M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.36 |
|
0.64 |
|
78.08% |
|
22.58% |
|
22.58% |
|
29.26% |
|
21.20% |
|
11.72% |
|
$579.92M |
|
-- |
|
-- |
|
-- |
|
0.50 |
|
2.76 |
|
8.11 |
|
44.98 |
|
19.36% |
|
20.28% |
|
9.19% |
|
12.32% |
|
$0.17 |
|
$0.03 |
|
$0.04 |
|